Literature DB >> 20130912

Analysis of related factors associated with radiation pneumonitis in patients with locally advanced non-small-cell lung cancer treated with three-dimensional conformal radiotherapy.

Jun Dang1, Guang Li, Xiaobe Lu, Lei Yao, Shuo Zhang, Zhan Yu.   

Abstract

PURPOSE: To investigate the correlation among DVH (lung dose-volume histogram) parameters, clinical factors, and grade > or = 2 radiation pneumonitis (RP) in patients with locally advanced non-small-cell lung cancer (NSCLC) treated with three-dimensional conformal radiotherapy (3D-CRT), and the differences between patients treated with 3D-CRT alone or that combined with chemotherapy on RP. PATIENTS AND METHODS: As much as 93 patients of stage III NSCLC were treated with 3D-CRT, among which 36 were treated with chemotherapy after 3D-CRT, 57 received 3D-CRT treatment alone. The radiation dose was 62.5-65 Gy (BED = 68-72.7 Gy).
RESULTS: The morbidity of grade > or = 2 RP was 49.5%, of which grade 2 and grade 3 were 33.3 and 16.1%, respectively. The morbidity of RP in those patients treated with chemotherapy after radiotherapy was evidently higher than that of patients treated with radiotherapy alone (61.1 vs. 42.1%). According to the single factor analysis, V5-V50 and MLD of both the ipsilateral and the whole lung were all related to the occurrence of RP; comparing grade 3 with grade 2 within the same group, except V45, V50, TV20, TV30, and TMLD, other parameters also had their statistical significance (P < 0.01); comparing the non-chemotherapy-treated group with the chemotherapy-treated group, TV30 and TV35 had their statistical significance. According to logistic regression analysis; the occurrence of RP was evidently associated with the comprehensive value of DVH parameters, chemotherapy, and gender. Chemotherapy has increased the risk of RP 7.6 times. The increase of each score in the comprehensive value of DVH parameters would increase the risk of RP 22.7 times.
CONCLUSION: The comprehensive values of DVH parameters, chemotherapy, and gender have independent effects on the occurrence of RP. Most of DVH parameters were associated with the occurrence of RP. The curve shape composed of multiple points in DVH parameters was more important than any single DVH parameter.

Entities:  

Mesh:

Year:  2010        PMID: 20130912     DOI: 10.1007/s00432-010-0764-4

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  23 in total

1.  Induction chemotherapy plus three-dimensional conformal radiation therapy in the definitive treatment of locally advanced non-small-cell lung cancer.

Authors:  S Sim; K E Rosenzweig; R Schindelheim; K K Ng; S A Leibel
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-11-01       Impact factor: 7.038

Review 2.  Pulmonary toxicity associated with the treatment of non-small cell lung cancer and the effects of cytoprotective strategies.

Authors:  Ramesh Gopal
Journal:  Semin Oncol       Date:  2005-04       Impact factor: 4.929

3.  Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy.

Authors:  Ellen D Yorke; Andrew Jackson; Kenneth E Rosenzweig; Scott A Merrick; Dorota Gabrys; Ennapadam S Venkatraman; Chandra M Burman; Steven A Leibel; C Clifton Ling
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-10-01       Impact factor: 7.038

Review 4.  Predicting risk of radiation-induced lung injury.

Authors:  Indira Madani; Kim De Ruyck; Hannelore Goeminne; Wilfried De Neve; Hubert Thierens; Jan Van Meerbeeck
Journal:  J Thorac Oncol       Date:  2007-09       Impact factor: 15.609

5.  Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT).

Authors:  Shulian Wang; Zhongxing Liao; Xiong Wei; Helen H Liu; Susan L Tucker; Chao-Su Hu; Rodhe Mohan; James D Cox; Ritsuko Komaki
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-09-25       Impact factor: 7.038

6.  Prediction of radiation pneumonitis: dose-volume histogram analysis in 62 patients with non-small cell lung cancer after three-dimensional conformal radiotherapy.

Authors:  T Piotrowski; M Matecka-Nowak; P Milecki
Journal:  Neoplasma       Date:  2005       Impact factor: 2.575

7.  Concurrent two-dimensional radiotherapy and weekly docetaxel in the treatment of stage III non-small cell lung cancer: a good local response but no good survival due to radiation pneumonitis.

Authors:  Hiroshi Onishi; Kengo Kuriyama; Motoshi Yamaguchi; Takafumi Komiyama; Shiho Tanaka; Tsutomu Araki; Keiichi Nishikawa; Hiroshi Ishihara
Journal:  Lung Cancer       Date:  2003-04       Impact factor: 5.705

8.  Improved local control with higher doses of radiation in large-volume stage III non-small-cell lung cancer.

Authors:  Ramesh Rengan; Kenneth E Rosenzweig; Ennapadam Venkatraman; Lawrence A Koutcher; Jana L Fox; Reena Nayak; Howard Amols; Ellen Yorke; Andrew Jackson; C Clifton Ling; Steven A Leibel
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-11-01       Impact factor: 7.038

9.  Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis.

Authors:  D Oetzel; P Schraube; F Hensley; G Sroka-Pérez; M Menke; M Flentje
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-09-30       Impact factor: 7.038

10.  Exceptionally high incidence of symptomatic grade 2-5 radiation pneumonitis after stereotactic radiation therapy for lung tumors.

Authors:  Hideomi Yamashita; Keiichi Nakagawa; Naoki Nakamura; Hiroki Koyanagi; Masao Tago; Hiroshi Igaki; Kenshiro Shiraishi; Nakashi Sasano; Kuni Ohtomo
Journal:  Radiat Oncol       Date:  2007-06-07       Impact factor: 3.481

View more
  17 in total

1.  Associated factors of radiation pneumonitis induced by precise radiotherapy in 186 elderly patients with esophageal cancer.

Authors:  Zhen Cui; Ye Tian; Bin He; Hongwei Li; Duojie Li; Jingjing Liu; Hanfei Cai; Jianjun Lou; Hao Jiang; Xueming Shen; Kaigui Peng
Journal:  Int J Clin Exp Med       Date:  2015-09-15

2.  Dose-volume histogram parameters for predicting radiation pneumonitis using receiver operating characteristic curve.

Authors:  Dongqing Wang; Jian Shi; Shaohua Liang; Shiyong Lu; Xiangjie Qi; Qiang Wang; Guojing Zheng; Sheng Wang; Kemin Zhang; Hongfu Liu
Journal:  Clin Transl Oncol       Date:  2012-09-14       Impact factor: 3.405

Review 3.  Prediction of radiation pneumonitis in lung cancer patients: a systematic review.

Authors:  Xiao-Jing Zhang; Jian-Guo Sun; Jie Sun; Hua Ming; Xin-Xin Wang; Lei Wu; Zheng-Tang Chen
Journal:  J Cancer Res Clin Oncol       Date:  2012-07-29       Impact factor: 4.553

Review 4.  A survey of changing trends in modelling radiation lung injury in mice: bringing out the good, the bad, and the uncertain.

Authors:  Mohamad B Dabjan; Carolyn Ms Buck; Isabel L Jackson; Zeljko Vujaskovic; Brian Marples; Julian D Down
Journal:  Lab Invest       Date:  2016-08-01       Impact factor: 5.662

5.  Symptomatic Radiation Pneumonitis in NSCLC Patients Receiving EGFR-TKIs and Concurrent Once-daily Thoracic Radiotherapy: Predicting the Value of Clinical and Dose-volume Histogram Parameters.

Authors:  Xuexi Yang; Ting Mei; Min Yu; Youling Gong
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2022-06-20

6.  Effect of normal lung definition on lung dosimetry and lung toxicity prediction in radiation therapy treatment planning.

Authors:  Weili Wang; Yaping Xu; Matthew Schipper; Martha M Matuszak; Timothy Ritter; Yue Cao; Randall K Ten Haken; Feng-Ming Spring Kong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-08-01       Impact factor: 7.038

7.  Functional dosimetric metrics for predicting radiation-induced lung injury in non-small cell lung cancer patients treated with chemoradiotherapy.

Authors:  Dongqing Wang; Jinbo Sun; Jingyu Zhu; Xiaohong Li; Yanbo Zhen; Songtao Sui
Journal:  Radiat Oncol       Date:  2012-05-17       Impact factor: 3.481

8.  Predictors of radiation pneumonitis and pulmonary function changes after concurrent chemoradiotherapy of non-small cell lung cancer.

Authors:  Young Hee Park; Jae-Sung Kim
Journal:  Radiat Oncol J       Date:  2013-03-31

9.  Fatal pneumonitis associated with postoperative intensity-modulated radiotherapy in lung cancer: Case report and review.

Authors:  Yan Hu; Jingjing Li; Xiaoyan Su
Journal:  Oncol Lett       Date:  2012-11-30       Impact factor: 2.967

10.  Association between absolute volumes of lung spared from low-dose irradiation and radiation-induced lung injury after intensity-modulated radiotherapy in lung cancer: a retrospective analysis.

Authors:  Jinmei Chen; Jinsheng Hong; Xi Zou; Wenlong Lv; Feibao Guo; Hualan Hong; Weijian Zhang
Journal:  J Radiat Res       Date:  2015-10-09       Impact factor: 2.724

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.